|Outcome||Relative effect 95%CI||LoD||Trt. better when||I2||k (RCT/OBS)||Bayesian probability||Overall ROB||Publication bias||Degree of certainty||Endpoint importance||Published MA|
|deaths||0.50 [0.09, 2.71]||< 1||0%||1 study (1/-)||78.8 %||low||not evaluable||high||crucial||-|
|clinical deterioration||0.52 [0.29, 0.94]||< 1||0%||1 study (1/-)||98.5 %||low||not evaluable||high||important||-|
|ICU admission||0.33 [0.07, 1.58]||< 1||0%||1 study (1/-)||91.7 %||low||not evaluable||high||non important||-|
LoD: level of demonstration ( demonstrated, suggested, inconclusive, safety concerns);
Bayesian probability: Bayesian posterior probability of treatment effect (computed with a noninformative prior); ROB: risk of bias; k: number of studies; published MA: number of published meta-analysis on the same topic; degree of certainty adapted from GRADE. Trt. better when: indicates when the relative treatment effect shows that the studied treatment is better than control.